MP27-01 CHARACTERISTICS OF PATIENTS WITH PERSISTENT LOWER URINARY TRACT SYMPTOMS AFTER HOLEP IN BPH

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology II1 Apr 2017MP27-01 CHARACTERISTICS OF PATIENTS WITH PERSISTENT LOWER URINARY TRACT SYMPTOMS AFTER HOLEP IN BPH Kang Sup Kim, Yong Sun Choi, Hong Jin Suh, Hyun Woo Kim, Joon Chul Kim, and Donh Hwan Lee Kang Sup KimKang Sup Kim More articles by this author , Yong Sun ChoiYong Sun Choi More articles by this author , Hong Jin SuhHong Jin Suh More articles by this author , Hyun Woo KimHyun Woo Kim More articles by this author , Joon Chul KimJoon Chul Kim More articles by this author , and Donh Hwan LeeDonh Hwan Lee More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.793AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Holmium laser enucleation of the prostate (HoLEP) in BPH is widely used and the effects are known to be equivalent or better than traditional TUR-P with low incidence of complications. However, some patients who underwent HoLEP still have the lower urinary tract symptoms(LUTS) after surgery. We evaluated the characteristics of patients who visited our clinics due to persistent LUTS and required additional medications after HoLEP in BPH patients. METHODS The medical records of the patients who underwent HoLEP from March of 2011 to June of 2015 were reviewed retrospectively. The analysis was performed in patients who have been followed for more than 6 months after surgery. The patients were divided into 2 groups. Group A is the patients with persistent obstructive symptoms and group B is with irritation symptoms. Age, prostate specific antigen, International prostate symptom score (IPSS), prostate volume, transition zone volume of prostate, peak flow rate, maximum cystometric capacity, post voided residual volume, resected weights, operation time were analyzed. RESULTS Among the 482 patients who underwent the HoLEP, the numbers of patients who required the medicine for lower urinary tract symptoms were 138 (28.6%). Among the patients, 53 patients (40.2%) were enrolled in Group A and 85 patients (59.8%) were enrolled in Group B. The mean age, total IPSS, PSA, total prostate volume, peak flow rate, maximum cystometric capacity, post voided residual volume, and operation time between two groups were statistically insignificant. However, transition zone volume and resected weights were significantly different between group A and B. (p=0.017, p=0.010 respectively) CONCLUSIONS More than 25% of the patients were still taking the medicines for lower urinary tract symptoms after HoLEP. Among the patients who required the medicine, 60% of patients have complained of irritation symptoms. Bigger transition zone with resection weights were correlated with remaining of postoperative irritation symptoms. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e328 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Kang Sup Kim More articles by this author Yong Sun Choi More articles by this author Hong Jin Suh More articles by this author Hyun Woo Kim More articles by this author Joon Chul Kim More articles by this author Donh Hwan Lee More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...